Table 3 |
|||
|
A comparison between the LR+RT+ and LR-RT+/LR-RT- subgroups |
|||
|
Factor |
LR+RT+ |
LR-RT+/LR-RT- |
P value |
|
|
|||
|
ER status, number |
|||
|
Negative |
10 |
11 |
|
|
Positive |
9 |
69 |
0.0007a |
|
Median age, years |
|||
|
All |
48 |
61 |
0.00004b |
|
ER- subgroup |
49.5 |
53 |
0.12 |
|
ER+ subgroup |
46 |
61 |
0.002 |
|
Histological grade, number |
|||
|
1 |
3 |
35 |
|
|
2 |
8 |
22 |
|
|
3 |
7 |
18 |
0.055a |
|
Median tumor size, millimeters |
15 |
15 |
0.95b |
|
|
|||
|
Only cases from inclusion 1 are included. aFisher exact test. bWilcoxon rank sum test. ER = estrogen receptor; LR-RT- = no local recurrence, no radiotherapy given; LR-RT+ = no local recurrence after radiotherapy; LR+RT+ = local recurrence developed after radiotherapy. |
|||
|
Niméus-Malmström et al. Breast Cancer Research 2008 10:R34 doi:10.1186/bcr1997 |
|||